- Home
- EVH vs MLTX Comparison
EVH vs MLTX Comparison
Compare EVH & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVH
- MLTX
- Stock Information
- Founded
- EVH 2011
- MLTX 2021
- Country
- EVH United States
- MLTX Switzerland
- Employees
- EVH N/A
- MLTX N/A
- Industry
- EVH Other Consumer Services
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- EVH Consumer Discretionary
- MLTX Health Care
- Exchange
- EVH Nasdaq
- MLTX Nasdaq
- Market Cap
- EVH 3.8B
- MLTX 3.4B
- IPO Year
- EVH 2015
- MLTX N/A
- Fundamental
- Price
- EVH $10.82
- MLTX $52.25
- Analyst Decision
- EVH Strong Buy
- MLTX Strong Buy
- Analyst Count
- EVH 10
- MLTX 9
- Target Price
- EVH $25.90
- MLTX $77.43
- AVG Volume (30 Days)
- EVH 2.6M
- MLTX 178.7K
- Earning Date
- EVH 11-07-2024
- MLTX 11-07-2024
- Dividend Yield
- EVH N/A
- MLTX N/A
- EPS Growth
- EVH N/A
- MLTX N/A
- EPS
- EVH N/A
- MLTX N/A
- Revenue
- EVH $2,464,254,000.00
- MLTX N/A
- Revenue This Year
- EVH $31.68
- MLTX N/A
- Revenue Next Year
- EVH $14.35
- MLTX N/A
- P/E Ratio
- EVH N/A
- MLTX N/A
- Revenue Growth
- EVH 37.65
- MLTX N/A
- 52 Week Low
- EVH $10.65
- MLTX $37.55
- 52 Week High
- EVH $35.00
- MLTX $64.98
- Technical
- Relative Strength Index (RSI)
- EVH 31.55
- MLTX 49.38
- Support Level
- EVH $10.70
- MLTX $50.60
- Resistance Level
- EVH $12.01
- MLTX $58.26
- Average True Range (ATR)
- EVH 0.54
- MLTX 2.75
- MACD
- EVH 0.37
- MLTX -0.14
- Stochastic Oscillator
- EVH 12.55
- MLTX 21.54
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.